Our reviews in guidelines

Cochrane Skin reviews have changed or informed international guidelines:

    Strategies for using topical corticosteroids in children and adults with eczema (Review, 2022)

    Phototherapy for atopic eczema (Review, 2021)

    Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis (Update 2021)

    • Finnish Medical Society Duodecim, Finnish Dermatology Association, Finnish Rheumatology Association. [Duodecim Current Care Guidelines: Psoriasis and psoriatic arthritis]. Helsinki: Finnish Medical Society Duodecim; February 2023. https://www.kaypahoito.fi/hoi50062 
    • Finnish Medical Society Duodecim, Finnish Dermatology Association, Finnish Rheumatology Association. [Duodecim Current Care Guidelines: Psoriasis and psoriatic arthritis]. Helsinki: Finnish Medical Society Duodecim; January 2022. https://www.kaypahoito.fi/hoi50062 
    • This Cochrane Review has had a direct influence on treatment of psoriasis in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. London: National Institute for Health and Care Excellence; 2022. [last revised September 2022]. https://cks.nice.org.uk/topics/psoriasis/
    • Finnish Medical Society Duodecim, Finnish Dermatology Association, Finnish Rheumatology Association. [Duodecim Current Care Guidelines: Psoriasis and psoriatic arthritis]. Helsinki: Finnish Medical Society Duodecim; November 2021. https://www.kaypahoito.fi/hoi50062 

    Interventions for mycosis fungoides (Update, 2020)

    Interventions for chronic pruritus of unknown origin (Review, 2020)

    Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis (Update, 2020)

    • National Institute for Health and Care Excellence. Technology appraisal guidance: Bimekizumab for treating moderate to severe plaque psoriasis. London: National Institute for Health and Care Excellence; 2021. (NICE TA723). [Issued September 2021]. https://www.nice.org.uk/guidance/ta723/evidence
    • [S3-Guideline: Treatment of psoriasis vulgaris - living guideline]. Nast A, Altenburg A,  Augustin M, Boehncke W-H, Härle P, Klaus J,  Koza J, Mrowietz U, Ockenfels H-M, Philipp S, Reich K, Rosenbach T, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T, Dressler C. Berlin: Deutsche Dermatologische Gesellschaft (DDG); 2021. https://www.awmf.org/uploads/tx_szleitlinien/013-001l_S3_Therapie-Psoriasis-vulgaris_2021-07.pdf
    • EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment nd monitoring recommendations. Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, De Jong E, Garcia-Doval I, Gisondi P, Kaur-Knudsen D, Mahil S, Mälkönen T, Maul JT, Mburu S, Mrowietz U, Reich K, Remenyik E, Rønholt KM, Sator PG, Schmitt-Egenolf M, Sikora M, Strömer K, Sundnes O, Trigos D, Van Der Kraaij G, Yawalkar N, Dressler C. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2461-2498. doi: 10.1111/jdv.16915. https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16915
    • EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations. Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, De Jong E, Garcia-Doval I, Gisondi P, Kaur-Knudsen D, Mahil S, Mälkönen T, Maul JT, Mburu S, Mrowietz U, Reich K, Remenyik E, Rønholt KM, Sator PG, Schmitt-Egenolf M, Sikora M, Strömer K, Sundnes O, Trigos D, Van Der Kraaij G, Yawalkar N, Dressler C. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):281-317. doi: 10.1111/jdv.16926. https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16926

    Systemic treatments for eczema: a network meta-analysis (Review, 2020)

    • Yao TC, Wang IJ, Sun HL, Ou LS, Yu HH, Wang L, Hung CH; Committee of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology. Taiwan guidelines for the diagnosis and management of pediatric atopic dermatitis: Consensus statement of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology. J Microbiol Immunol Infect. 2022 Aug;55(4):561-572. doi: 10.1016/j.jmii.2022.03.004. https://www.sciencedirect.com/science/article/pii/S1684118222000512?via%3Dihub
    • National Institute for Health and Care Excellence. Technology appraisal guidance: Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis. London: National Institute for Health and Care Excellence; 2022. (NICE TA814). [Issued August 2022]. https://www.nice.org.uk/guidance/ta814/evidence

    Topical and device-based treatments for fungal infections of the toenails (Review, 2020)

    Interventions for hand eczema (Review, 2019)

    Lifestyle changes for treating psoriasis (Review, 2019)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. London: National Institute for Health and Care Excellence; 2022. [last revised September 2022]. https://cks.nice.org.uk/topics/psoriasis/

    Antistreptococcal interventions for guttate and chronic plaque psoriasis (Update, 2019)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. London: National Institute for Health and Care Excellence; 2022. [last revised September 2022]. https://cks.nice.org.uk/topics/psoriasis/

    Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis (Review, 2019)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. London: National Institute for Health and Care Excellence; 2022. [last revised September 2022]. https://cks.nice.org.uk/topics/psoriasis/
    •  Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Siegel M, Stoff B, Strober B, Wu JJ, Hariharan V, Menter A. J Am Acad Dermatol. 2021 Feb;84(2):432-470. doi: 10.1016/j.jaad.2020.07.087. https://www.jaad.org/action/showPdf?pii=S0190-9622%2820%2932288-X

    Interventions for infantile seborrhoeic dermatitis (including cradle cap) (Review, 2019)

    • This Cochrane Review has had a direct influence on treatment of seborrhoeic dermatitis in general practice through CKS: 

    Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma (Review, 2019)

    Interventions to reduce Staphylococcus aureus in the management of eczema (Update, 2019)

    • Yao TC, Wang IJ, Sun HL, Ou LS, Yu HH, Wang L, Hung CH; Committee of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology. Taiwan guidelines for the diagnosis and management of pediatric atopic dermatitis: Consensus statement of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology. J Microbiol Immunol Infect. 2022 Aug;55(4):561-572. doi: 10.1016/j.jmii.2022.03.004. https://www.sciencedirect.com/science/article/pii/S1684118222000512?via%3Dihub
    • National Institute for Health and Care Excellence; Public Health England. Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing. London: National Institute for Health and Care Excellence; 2021. (NICE NG190). [Issued March 2021]. https://www.nice.org.uk/guidance/ng190

    Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema (Review, 2019)

    • [Guidelines on atopic dermatitis for Mexico (GUIDAMEX): using the ADAPTE methodology]. Gac Med Mex. 2023 Jan 20;158(Suplement 2):1-116. https://www.gacetamedicademexico.com/files/es/gmm_22_158_s2_001-116.pdf
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2022. [Last revised April 2022]. https://cks.nice.org.uk/topics/eczema-atopic/
    • This review was cited in:
      • The part II of the European guideline (EuroGuiDerm) on atopic eczema: Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18429

    Interventions for preventing occupational irritant hand dermatitis (update, 2018)

    Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults (Review, 2018)

    • European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer. 2022 Jul;170:236-255. doi: 10.1016/j.ejca.2022.03.008. https://www.ejcancer.com/action/showPdf?pii=S0959-8049%2822%2900152-6

    Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults (Review, 2018)

    • European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer. 2022 Jul;170:236-255. doi: 10.1016/j.ejca.2022.03.008. https://www.ejcancer.com/action/showPdf?pii=S0959-8049%2822%2900152-6
    • SEOM clinical guideline for the management of cutaneous melanoma (2020). Majem M, Manzano JL, Marquez-Rodas I, Mujika K, Muñoz-Couselo E, Pérez-Ruiz E, de la Cruz-Merino L, Espinosa E, Gonzalez-Cao M, Berrocal A. Clin Transl Oncol. 2021 May;23(5):948-960. doi: 10.1007/s12094-020-02539-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057998/pdf/12094_2020_Article_2539.pdf

    High-frequency ultrasound for diagnosing skin cancer in adults (Review, 2018)

    Probiotics for treating eczema (Update, 2018)

    This review was cited in:

    • The part II of the European guideline (EuroGuiDerm) on atopic eczema: Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18429

    Systemic treatments for metastatic cutaneous melanoma (Review, 2018)

    • National Collaborating Centre for Cancer. National Institute for Health and Care Excellence (commissioner). Melanoma: assessment and management. London: National Institute for Health and Care Excellence; 2022. (NICE NG14). [Issued July 2015; updated July 2022]. http://www.nice.org.uk/guidance/NG14/evidence

    Interventions for the prevention of recurrent erysipelas and cellulitis (Review, 2017)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Cellulitis - acute. London: National Institute for Health and Care Excellence; 2021.  [last revised January 2021]. https://cks.nice.org.uk/topics/cellulitis-acute/

    Emollients and moisturisers for eczema (Review, 2017)

    This review was cited in:

    • The part II of the European guideline (EuroGuiDerm) on atopic eczema: Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18429
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2022. [Last revised April 2022]. https://cks.nice.org.uk/topics/eczema-atopic/
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. London: National Institute for Health and Care Excellence; 2022. [last revised September 2022]. https://cks.nice.org.uk/topics/psoriasis/
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2021. [Last revised January 2021]. https://cks.nice.org.uk/topics/eczema-atopic/

    Interventions for cutaneous molluscum contagiosum (Update, 2017)

    Topical treatments for scalp psoriasis (Review, 2016)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. London: National Institute for Health and Care Excellence; 2022. [last revised September 2022]. https://cks.nice.org.uk/topics/psoriasis/

    Systemic antifungal therapy for tinea capitis in children (Update, 2016)

    Interventions for female pattern hair loss (Update, 2016)

    Interventions for XInterventions for prevention of herpes simplex labialis (cold sores on the lips) (Review, 2015)

    Topical antifungals for seborrhoeic dermatitis (Update, 2015)

    • This Cochrane Review has had a direct influence on treatment of seborrhoeic dermatitis in general practice through CKS

    Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma (Review, 2015)

    Topical tacrolimus for atopic dermatitis (Review, 2015)

    This review was cited in:

    • The part II of the European guideline (EuroGuiDerm) on atopic eczema: Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18429

    House dust mite reduction and avoidance measures for treating eczema (Review, 2015)

    This review was cited in:

    • The part II of the European guideline (EuroGuiDerm) on atopic eczema: Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18429
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2022. [Last revised April 2022]. https://cks.nice.org.uk/topics/eczema-atopic/
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2021. [Last revised January 2021]. https://cks.nice.org.uk/topics/eczema-atopic/

    Interventions for rosacea (Update, 2015)

    Interventions for vitiligo (Update, 2015)

    Safety of topical corticosteroids in pregnancy (Update, 2015)

    • This review has been chosen as one of the reviews that may feed into the next planned WHO Guideline, which will be on Antenatal Care (ANC).
    • Finnish Medical Society Duodecim, Finnish Dermatology Association, Finnish Rheumatology Association. [Duodecim Current Care Guidelines: Psoriasis and psoriatic arthritis]. Helsinki: Finnish Medical Society Duodecim; February 2023. https://www.kaypahoito.fi/hoi50062 
    • Finnish Medical Society Duodecim, Finnish Dermatology Association, Finnish Rheumatology Association. [Duodecim Current Care Guidelines: Psoriasis and psoriatic arthritis]. Helsinki: Finnish Medical Society Duodecim; January 2022. https://www.kaypahoito.fi/hoi50062 
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Corticosteroids - topical (skin), nose, and eyes. London: National Institute for Health and Care Excellence; 2022. [last revised June 2022]. https://cks.nice.org.uk/topics/corticosteroids-topical-skin-nose-eyes/
    • This review was cited in:
      • The part II of the European guideline (EuroGuiDerm) on atopic eczema: Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18429
      • O'Kane D, McCourt C, Meggitt S, D'Cruz DP, Orteu CH, Benton E, Wahie S, Utton S, Hashme M, Mohd Mustapa MF, Exton LS; British Association of Dermatologists’ Clinical Standards Unit. British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021. Br J Dermatol. 2021 Dec;185(6):1112-1123. https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.20597
      • Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Siegel M, Stoff B, Strober B, Wu JJ, Hariharan V, Menter A. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021 Feb;84(2):432-470. https://www.jaad.org/action/showPdf?pii=S0190-9622%2820%2932288-X
    • Finnish Medical Society Duodecim, Finnish Dermatology Association, Finnish Rheumatology Association. [Duodecim Current Care Guidelines: Psoriasis and psoriatic arthritis]. Helsinki: Finnish Medical Society Duodecim; November 2021. https://www.kaypahoito.fi/hoi50062 

    Oral fumaric acid esters for psoriasis (Review, 2015)

    • A Medicines Q&A reviews evidence for efficacy and safety of Fumaderm® in treating psoriasis. Prepared by UK Medicines Information (UKMi) pharmacists for NHS healthcare professionals.

    Interventions for the treatment of pityriasis versicolor (Protocol, 2014)

    Topical anti‐inflammatory agents for seborrhoeic dermatitis of the face or scalp (Review, 2014)

    • This Cochrane Review has had a direct influence on treatment of seborrhoeic dermatitis in general practice through CKS

    H1-antihistamines for chronic spontaneous urticaria (Review, 2014)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Urticaria. London: National Institute for Health and Care Excellence; 2022.  [last revised September 2022]. https://cks.nice.org.uk/urticaria
    • Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the Centre of Evidence of the French Society of Dermatology. Hacard F, Giraudeau B, d'Acremont G, Jegou MH, Jonville-Bera AP, Munck S, Pham BN, Mavoungou S, Cornillier H, Guillot B, Beylot-Barry M, Chosidow O, Maruani A. Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20415. [Epub ahead of print]. https://onlinelibrary.wiley.com/doi/10.1111/bjd.20415
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Urticaria. London: National Institute for Health and Care Excellence; 2021.  [last revised August 2021]. https://cks.nice.org.uk/urticaria
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Angio-oedema and anaphylaxis. London: National Institute for Health and Care Excellence; 2021. [last revised September 2021]. https://cks.nice.org.uk/topics/angio-oedema-anaphylaxis/

    Interventions for melanoma in situ, including lentigo maligna (Review, 2014)

    • National Collaborating Centre for Cancer. National Institute for Health and Care Excellence (commissioner). Melanoma: assessment and management. London: National Institute for Health and Care Excellence; 2022. (NICE NG14). [Issued July 2015; updated July 2022]. http://www.nice.org.uk/guidance/NG14/evidence
    • European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022. Eur J Cancer. 2022 Jul;170:256-284. https://www.ejcancer.com/action/showPdf?pii=S0959-8049%2822%2900228-3

    Psychological and educational interventions for atopic eczema in children (Update, 2014)

    • [Guidelines on atopic dermatitis for Mexico (GUIDAMEX): using the ADAPTE methodology]. Gac Med Mex. 2023 Jan 20;158(Suplement 2):1-116. https://www.gacetamedicademexico.com/files/es/gmm_22_158_s2_001-116.pdf
    • This review was cited in:
      • The part II of the European guideline (EuroGuiDerm) on atopic eczema: Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18429

    Topical antifungal treatments for tinea cruris and tinea corporis (Review, 2014)

    Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp (Review, 2014)

    Interventions for nail psoriasis (Review, 2013)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. London: National Institute for Health and Care Excellence; 2022. [last revised September 2022]. https://cks.nice.org.uk/topics/psoriasis/

    Topical treatments for chronic plaque psoriasis (Update, 2013)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. London: National Institute for Health and Care Excellence; 2022. [last revised September 2022]. https://cks.nice.org.uk/topics/psoriasis/
    • Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Siegel M, Stoff B, Strober B, Wu JJ, Hariharan V, Menter A. J Am Acad Dermatol. 2021 Feb;84(2):432-470. doi: 10.1016/j.jaad.2020.07.087. https://www.jaad.org/action/showPdf?pii=S0190-9622%2820%2932288-X

    Chinese herbal medicine for atopic eczema (Review, 2013)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2022. [Last revised April 2022].  https://cks.nice.org.uk/topics/eczema-atopic/
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2021. [Last revised January 2021]. https://cks.nice.org.uk/topics/eczema-atopic/

    Interventions for cutaneous Bowen's disease (Review, 2013)

    Oral evening primrose oil and borage oil for eczema (Review, 2013)

    • This review was cited in:
      • The part II of the European guideline (EuroGuiDerm) on atopic eczema: Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18429
      • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2022. [Last revised April 2022]. https://cks.nice.org.uk/topics/eczema-atopic/
      • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2021. [Last revised January 2021]. https://cks.nice.org.uk/topics/eczema-atopic/

    Topical treatments for chronic plaque psoriasis (Update, 2013)

    • This Cochrane Review has had a direct influence on treatment of psoriasis in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September. http://cks.nice.org.uk/psoriasis
    • Evidence Update November 2014. A summary of selected new evidence relevant to NICE clinical guideline 153 ‘The assessment and management of psoriasis’ (2012). https://www.nice.org.uk/guidance/cg153/evidence/evidence-update-pdf-188313949

    Interventions for nail psoriasis (Review, 2013)

    • Dutch psoriasis guideline update 2013-2014

    Chinese herbal medicine for atopic eczema (Review, 2013)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2021. [Last revised January 2021]. https://cks.nice.org.uk/topics/eczema-atopic/
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2022. [Last revised April 2022]. https://cks.nice.org.uk/topics/eczema-atopic/

    Interferon alpha for the adjuvant treatment of cutaneous melanoma (Review, 2013)

    Interventions for cutaneous Bowen's disease (Review, 2013)

    • The review was cited in the BAD’s guidelines for the management of squamous cell carcinoma in situ (Bowen’s disease): Morton CA, Birnie AJ, Eedy DJ. British Association of Dermatologists’ guidelines for the management of squamous cell carcinoma in situ (Bowen’s disease) 2014. British Journal of Dermatology 2014; 179: 245-60. https://academic.oup.com/bjd/article/170/2/245/6614755?login=false

    Interventions for female pattern hair loss (Review, 2012)

    Histamine H2-receptor antagonists for urticaria (Review, 2012)

    • [Dutch College of General Practitioners – Guideline on the treatment of urticaria and angio-oedema (version 2.1)]. Utrecht: Nederlands Huisartsen Genootschap; June 2022. https://richtlijnen.nhg.org/files/pdf/113_Urticaria%20en%20angio-oedeem_juni-2022.pdf
    • Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the Centre of Evidence of the French Society of Dermatology. Hacard F, Giraudeau B, d'Acremont G, Jegou MH, Jonville-Bera AP, Munck S, Pham BN, Mavoungou S, Cornillier H, Guillot B, Beylot-Barry M, Chosidow O, Maruani A. Br J Dermatol. 2021 Apr 29. [Epub ahead of print]. https://onlinelibrary.wiley.com/doi/10.1111/bjd.20415
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Urticaria. London: National Institute for Health and Care Excellence; 2021.  [last revised August 2021]. https://cks.nice.org.uk/urticaria

    Interventions for actinic keratoses (Review, 2012)

    Dietary supplements for established atopic eczema (Review, 2012)

    This review was cited in:

    • The part II of the European guideline (EuroGuiDerm) on atopic eczema: Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18429

    Interventions for erosive lichen planus affecting mucosal sites (Review, 2012)

    Venom immunotherapy for preventing allergic reactions to insect stings (Review, 2012)

    Histamine H2-receptor antagonists for urticaria (Review, 2012)

    • Methods report on the development of the 2013 revision and update of the EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. http://www.ga2len.net/PDF/Methods.pdf.  In this document the authors noted this review ‘found that evidence does not support the previous recommendation to use H2-AHs because evidence of efficacy is lacking in view of the fact that no new studies have been performed. H2-AHs are thus not recommended in the algorithm of treatment (strong recommendation/high-quality evidence) but could in individual cases be considered as alternative treatment in level 3 as the costs are very low and they are available worldwide (weak recommendation/lowquality evidence)’.
    • Dutch guideline on chronic urticaria published 2015.

    Oral treatments for fungal infections of the skin of the foot (Update, 2012)

    • The updated Cochrane Review has had a direct influence on treatment and management of fungal skin infections of the foot in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries (CKS): Fungal skin infection - foot. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September. http://cks.nice.org.uk/fungal-skin-infection-foot. 
    • Dutch College of General Practitioners – Guideline on dermatomycoses (version 3.0 – Guideline M64)]. Utrecht: Nederlands Huisartsen Genootschap; February 2022. https://richtlijnen.nhg.org/files/pdf/78_Dermatomycosen_februari-2022.pdf
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Fungal skin infection - foot. London: National Institute for Health and Care Excellence; 2022. [last revised July 2022]. https://cks.nice.org.uk/topics/fungal-skin-infection-foot/

    Topical treatments for cutaneous warts (Update, 2012)

    • The update was cited in the BAD’s guidelines for the management of cutaneous warts. Sterling JC, Gibbs S, Haque Hussain SS, Mohammed Mustapa MF, Handfield-Jones SE. British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. British Journal of Dermatology 2014; 171:696-712. https://doi.org/10.1111/bjd.13310

    Dietary supplements for established atopic eczema (Update, 2012)

    Minocycline for acne vulgaris: efficacy and safety (Update, 2012)

    • This Cochrane Review has had a direct influence on treatment of acne vulgaris in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Acne vulgaris. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September. http://cks.nice.org.uk/acne-vulgaris

    Interventions for impetigo (Review, 2012)

    • This Cochrane Review has had a direct influence on treatment of impetigo in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Impetigo. London: National Institute for Health and Care Excellence; 2013 July http://cks.nice.org.uk/impetigo

    Interventions for actinic keratosis (Review, 2012)

    • The International League of Dermatological Societies (ILDS)  and the European Skin Cancer Foundation (ESCF) commissioned guidelines for actinic keratoses: 'International Evidence-based (S3) Guidelines for the Treatment of Actinic Keratosis'

    Topical interventions for genital lichen sclerosus (Review, 2011)

    Interventions for rosacea (Update, 2011)

    Topical interventions for genital lichen sclerosus (Review, 2011)

    nterventions for cellulitis and erysipelas (Review, 2010)

    • Scientific Medical Policy Committee of the American College of Physicians, Akl EA, Bledsoe TA, Forciea MA, Haeme R, Kansagara DL, Marcucci M, Miller MC, Obley AJ. Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians. Lee RA, Centor RM, Humphrey LL, Jokela JA, Andrews R, Qaseem A. Ann Intern Med. 2021 Jun;174(6):822-827. doi: 10.7326/M20-7355. https://www.acpjournals.org/doi/10.7326/M20-7355
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Cellulitis - acute. London: National Institute for Health and Care Excellence; 2021.  [last revised January 2021]. https://cks.nice.org.uk/topics/cellulitis-acute/

    Interventions for vitiligo (Update, 2010)

    Interventions for melasma (Review, 2010)

    Interventions for vitiligo (Update, 2010)

    This updated review has had a direct influence on treatment and management of vitiligo in general practice through CKS. The NICE CKS guidance is extremely important as the majority of vitiligo patients are treated in primary care and very little advice has been available for patients and GPs on the most appropriate treatments to use:

    The following guideline summarised evidence and made recommendations on treatments for vitiligo. The updated vitiligo Cochrane Review and vitiligo prioritisation exercise fed into the guideline development process.

    • Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Taieb A, Alomar A, Böhm M, Dell'anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M; Vitiligo European Task Force (VETF); European Academy of Dermatology and Venereology (EADV); Union Europe´enne des Me´decins Spe´cialistes (UEMS). Br J Dermatol. 2013 Jan;168(1):5-19. doi: 10.1111/j.1365-2133.2012.11197.x. Epub 2012 Nov 2. http://www.euroderm.org/edf/index.php/edf-guidelines/category/5-guidelines-miscellaneous
    • This review was the key evidence source for NHS Choices topic on vitiligo and for the way vitiligo treatments were disseminated to patients and health professionals. This NHS Choices information resource on vitiligo is extremely important, as the majority of vitiligo patients are treated in primary care and very little advice has been available for patients and GPs on the most appropriate treatments to use. http://www.nhs.uk/Conditions/Vitiligo/Pages/Introd uction.aspx
    • Guidelines for designing and reporting clinical trials in vitiligo. González U, Whitton M, Eleftheriadou V, Pinart M, Batchelor J, Leonardi-Bee J. Arch Dermatol. 2011 ec;147(12):1428-36. doi: 0.1001/archdermatol.2011.235. Epub 2011 Aug 15. Review. http://www.ncbi.nlm.nih.gov/pubmed/21844427
    • The 2010 Cochrane Review on vitiligo was used as a key evidence source for the concise version of the BAD guidelines on vitiligo published in 2010 in Postgrad Med J 2010;86:466-471. http://pmj.bmj.com/content/86/1018/466.full

    Interventions for cellulitis and erysipelas (Review, 2010)

    • This review has had a direct influence on treatment of acute cellulitis in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Cellulitis - acute. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September. http://cks.nice.org.uk/cellulitis-acute
    • Dutch guidelines for erysipelas and cellulitis. Authors have used the review to support a new local clinical guideline (University Hospitals Bristol) and one author, Dr Richard Brindle, has written to the BNF asking them to make some changes to the summary of antibacterial therapy section using the review as part of the evidence.

    Interventions for preventing occupational irritant hand dermatitis (Review, 2010)

    • This Cochrane Review has had a direct influence on treatment of contact dermatitis in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Dermatitis - contact. London: National Institute for Health and Care Excellence; 2013 March. http://cks.nice.org.uk/dermatitis-contact

    Interventions for bullous pemphigoid (Update, 2010)

    Interventions for non-metastatic squamous cell carcinoma of the skin (Review, 2010)

    • Systematic review of interventions for non-metastatic squamous cell carcinoma of the skin used as key evidence source for SIGN Guideline: SIGN Guideline 140: Management of primary cutaneous squamous cell carcinoma. http://www.sign.ac.uk/assets/sign140.pdf .  The final document acknowledges the Cochrane authors major contribution to the development of this guideline.
    • NICE Improving outcomes for people with skin tumours including melanoma: Evidence Update October 2011. https://www.nice.org.uk/guidance/csgstim/evidence/skin-tumours-including-melanoma-evidence-update2
    • Systematic review of treatments for squamous cell carcinoma was key evidence source for NHS Choices topic on skin cancer (non-melanoma). http://www.nhs.uk/conditions/cancer-of-the-skin/Pages/Introduction.aspx. The NHS Choices non-melanoma skin cancer topic is a key way in which the findings of the systematic review of treatments for squamous cell carcinoma were disseminated to patients and health professionals.
    • This review fed into European consensus-based interdisciplinary guideline on diagnosis and treatment of invasive squamous cell carcinoma of the skin: Systematic review on interventions for squamous cell carcinoma used in European consensus-based guidelines: Alexander Stratigos, Claus Garbe, Celeste Lebbe, Josep Malvehy, Veronique del Marmol, Hubert Pehamberger, Ketty Peris, Jürgen C. Becker, Iris Zalaudek, Philippe Saiag, Mark R. Middleton, Lars Bastholt, Alessandro Testori, Jean-Jacques Grob, Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline, European Journal of Cancer, Volume 51, Issue 14, September 2015, Pages 1989-2007, ISSN 0959-8049, http://dx.doi.org/10.1016/j.ejca.2015.06.110.

    Interventions for cutaneous molluscum contagiosum (Update, 2009)

    Surgical excision margins for primary cutaneous melanoma (Review, 2009)

    • National Collaborating Centre for Cancer. National Institute for Health and Care Excellence (commissioner). Melanoma: assessment and management. London: National Institute for Health and Care Excellence; 2022. (NICE NG14). [Issued July 2015; updated July 2022]. http://www.nice.org.uk/guidance/NG14/evidence

    Interventions for cutaneous molluscum contagiosum (Review, 2009)

    Topical treatments for chronic plaque psoriasis (Review, 2009)

    • National Institute for Health and Clinical Excellence. Psoriasis: assessment and management of psoriasis. http://www.nice.org.uk/guidance/cg153/evidence
    • Nast A., Boehncke W.H., Mrowietz U., et al. S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. JDDG - Journal of the German Society of Dermatology, 2012, 10(SUPPL.2), S1-S95

    Surgical excision margins for primary cutaneous melanoma (Review, 2009)

    Dietary exclusions for established atopic eczema (Review, 2008)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2022. [Last revised April 2022]. https://cks.nice.org.uk/topics/eczema-atopic/
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Eczema - atopic.  London: National Institute for Health and Care Excellence; 2021. [Last revised January 2021]. https://cks.nice.org.uk/topics/eczema-atopic/

    Interventions for alopecia areata (Review, 2008)

    Probiotics for treating eczema (Review, 2008)

    Interventions to reduce Staphylococcus aureus in the management of atopic eczema (Review, 2008)

    • Scottish Intercollegiate Guidelines Network (SIGN). Management of atopic eczema in primary care. Edinburgh: SIGN; 2011. (SIGN publication no. 125 http://www.sign.ac.uk/assets/sign125.pdf)
    • This review was included in the American Academy of Dermatology’s Guidelines of care for the management of atopic dermatitis. Section 2: Eichenfield LF; Tom WL; Berger TG; Krol A; Paller AS; Schwarzenberger K; Bergman JN; Chamlin SL; Cohen DE; Cooper KD; Cordoro KM; Davis DM; Feldman SR; Hanifin JM; Margolis DJ; Silverman RA; Simpson EL; Williams HC; Elmets CA; Block J; Harrod CG; Smith Begolka W; Sidbury R, American Academy of Dermatology. Guidelines of care for the management of atopic dermatitis. Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 2014;71(1):116-32. http://www.aad.org/File%20Library/Global%20navigation/Education%20and%20quality%20care/AD-part-2.pdf
    • This review was included in the American Academy of Dermatology’s Guidelines of care for the management of atopic dermatitis. Section 3: Sidbury R; Davis DM; Cohen DE; Cordoro KM; Berger TG; Bergman JN; Chamlin SL; Cooper KD; Feldman SR; Hanifin JM; Krol A; Margolis DJ; Paller AS; Schwarzenberger K; Silverman RA; Simpson EL; Tom WL; Williams HC; Elmets CA; Block J; Harrod CG; Begolka WS; Eichenfield LF, American Academy of Dermatology. Guidelines of care for the management of atopic dermatitis. Section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol 2014;71(2):327-49. http://www.aad.org/File%20Library/Global%20navigation/Education%20and%20quality%20care/AD-part-3.pdf
    • Lynda Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, Novak N, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology. AAAAI/ACAAI Allergy Practice Parameter: Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol 2013; 131(2): 295-9 e27. http://www.allergyparameters.org/published-practice-parameters/alphabetical-listing/dermatitis-download/

    Dietary exclusions for established atopic eczema (Review, 2008)

    Interventions for basal cell carcinoma of the skin (Update, 2007)

    • British Association of Dermatologists’ Clinical Standards Unit. British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021. Nasr I, McGrath EJ, Harwood CA, Botting J, Buckley P, Budny PG, Fairbrother P, Fife K, Gupta G, Hashme M, Hoey S, Lear JT, Mallipeddi R, Mallon E, Motley RJ, Newlands C, Newman J, Pynn EV, Shroff N, Slater DN, Exton LS, Mohd Mustapa MF, Ezejimofor MC. Br J Dermatol. 2021 Nov;185(5):899-920. doi: 10.1111/bjd.20524. https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.20524

    Psychological and educational interventions for atopic eczema in children (Review, 2007)

    • National Collaborating Centre for Primary Care; National Institute for Health and Care Excellence (commissioner). Atopic eczema in under 12s: diagnosis and management. London: Royal College of Obstetricians and Gynaecologists; 2021. (NICE CG57). [Issued December 2007; updated March 2021]. https://www.nice.org.uk/guidance/cg57

    Interventions for preventing non-melanoma skin cancers in high-risk groups (Review, 2007)

    • [S3-Guideline: Treatment of psoriasis vulgaris - living guideline]. Nast A, Altenburg A,  Augustin M, Boehncke W-H, Härle P, Klaus J,  Koza J, Mrowietz U, Ockenfels H-M, Philipp S, Reich K, Rosenbach T, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T, Dressler C. Berlin: Deutsche Dermatologische Gesellschaft (DDG); 2021. https://www.awmf.org/uploads/tx_szleitlinien/013-001l_S3_Therapie-Psoriasis-vulgaris_2021-07.pdf
    • EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations. Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, De Jong E, Garcia-Doval I, Gisondi P, Kaur-Knudsen D, Mahil S, Mälkönen T, Maul JT, Mburu S, Mrowietz U, Reich K, Remenyik E, Rønholt KM, Sator PG, Schmitt-Egenolf M, Sikora M, Strömer K, Sundnes O, Trigos D, Van Der Kraaij G, Yawalkar N, Dressler C. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):281-317. doi: 10.1111/jdv.16926. https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16926

    Topical treatments for fungal infections of the skin and nails of the foot (Update, 2007)

    This updated Cochrane Review has had a direct influence on treatment and management of fungal skin infections of the foot and fungal nail infections in general practice through CKS and was cited in the BAD’s guidelines for the management of onychomycosis:

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Fungal skin infection - foot. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September. http://cks.nice.org.uk/fungal-skin-infection-foot
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Fungal nail infection. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September. http://cks.nice.org.uk/fungal-nail-infection
    • Ameen M; Lear JT; Madan V; Mohd Mustapa MF; Richardson M. British Association of Dermatologists’ guidelines for the management of onychomycosis 2014. British Journal of Dermatology 2014;171:937-58. https://doi.org/10.1111/bjd.13358
    • Dutch College of General Practitioners – Guideline on dermatomycoses (version 3.0 – Guideline M64)]. Utrecht: Nederlands Huisartsen Genootschap; February 2022. https://richtlijnen.nhg.org/files/pdf/78_Dermatomycosen_februari-2022.pdf
    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Fungal skin infection - foot. London: National Institute for Health and Care Excellence; 2022. [last revised July 2022]. https://cks.nice.org.uk/topics/fungal-skin-infection-foot/
    • Finnish Dermatologists’ Association. Duodecim Käypä Hoito: Ihninfektiot. [Duodecim Current Care Guidelines: Skin infections]. Helsinki: Finnish Medical Society Duodecim; March 2021. https://www.kaypahoito.fi/hoi50125
    • Finnish Medical Society Duodecim, Finnish Association of Dermatologists. Duodecim Käypä Hoito: Ihoinfektiot. [Duodecim Current Care Guidelines: Skin infections]. Helsinki: Finnish Medical Society Duodecim; October 2021. https://www.kaypahoito.fi/hoi50125

    Interventions for preventing non-melanoma skin cancers in high-risk groups (Review, 2007)

    • [S3-Guideline: Treatment of psoriasis vulgaris - living guideline]. Nast A, Altenburg A,  Augustin M, Boehncke W-H, Härle P, Klaus J,  Koza J, Mrowietz U, Ockenfels H-M, Philipp S, Reich K, Rosenbach T, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T, Dressler C. Berlin: Deutsche Dermatologische Gesellschaft (DDG); 2021. https://www.awmf.org/uploads/tx_szleitlinien/013-001l_S3_Therapie-Psoriasis-vulgaris_2021-07.pdf
    • EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations. Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, De Jong E, Garcia-Doval I, Gisondi P, Kaur-Knudsen D, Mahil S, Mälkönen T, Maul JT, Mburu S, Mrowietz U, Reich K, Remenyik E, Rønholt KM, Sator PG, Schmitt-Egenolf M, Sikora M, Strömer K, Sundnes O, Trigos D, Van Der Kraaij G, Yawalkar N, Dressler C. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):281-317. doi: 10.1111/jdv.16926. https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16926

    Topical pimecrolimus for eczema (Review, 2007)

    Interventions for preventing non-melanoma skin cancers in high-risk groups (Review, 2007)

    • European S3-Guidelines on the systemic treatment of psoriasis vulgaris. Update 2015. EDF in cooperation with EADV and IPC. 

    Systemic antifungal therapy for tinea capitis in children (Review, 2007)

    • This Cochrane Review has had a direct influence on treatment of fungal skin infections of the scalp in general practice through CKS and was cited in the BAD’s guidelines for the management of tinea capitis: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Fungal skin infection - scalp. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September http://cks.nice.org.uk/fungal-skin-infection-scalp
    • Fuller LC; Barton RC; Mohammed Mustapa MF; Proudfoot LE; Punjabi SP; Higgins EM. British Association of Dermatologists’ guidelines for the management of tinea capitis 2014. British Journal of Dermatology 2014;171:454-63. https://doi.org/10.1111/bjd.13196

    Psychological and educational interventions for atopic eczema in children (Review, 2007)

    • National Collaborating Centre for Women’s and Children’s Health; National Institute for Health and Clinical Excellence. Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years. London: Royal College of Obstetricians and Gynaecologists; 2007. (NICE CG57). [Issued December 2007] http://guidance.nice.org.uk
    • Scottish Intercollegiate Guidelines Network (SIGN). Management of atopic eczema in primary care. Edinburgh: SIGN; 2011. (SIGN publication no. 125 http://www.sign.ac.uk/assets/sign125.pdf)
    • HTA have commissioned an evidence synthesis on education for eczema to be done by NICE TAR team, in which the review is cited. http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0016/106153/PRO-13-11-01.pdf

    Disposable nappies for preventing napkin dermatitis in infants (Review, 2006)

    • National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Nappy rash. London: National Institute for Health and Care Excellence; 2022. [last revised July 2022]. https://cks.nice.org.uk/topics/nappy-rash/

    Interventions for chronic palmoplantar pustulosis (Review, 2006)

    • This review has had a direct influence on treatment of psoriasis in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September
    • European Dermatology Forum Guideline on Steroids in Pregnancy. 

    Disposable nappies for preventing napkin dermatitis in infants (Review 2006)

    • This Cochrane Review has had a direct influence on treatment of nappy rash in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Nappy rash. London: National Institute for Health and Care Excellence; 2013 July. http://cks.nice.org.uk/nappy-rash

    Topical Vitamin A, or its derivatives, for treating and preventing napkin dermatitis in infants (Review 2005)

    • This Cochrane Review has had a direct influence on treatment of nappy rash in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Nappy rash. London: National Institute for Health and Care Excellence; 2013 July. http://cks.nice.org.uk/nappy-rash

    Chinese herbal medicine for atopic eczema (Review, 2004)

    • Scottish Intercollegiate Guidelines Network (SIGN). Management of atopic eczema in primary care. Edinburgh: SIGN; 2011. (SIGN publication no. 125 http://www.sign.ac.uk/assets/sign125.pdf)
    • National Collaborating Centre for Women’s and Children’s Health; National Institute for Health and Clinical Excellence. Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years. London: Royal College of Obstetricians and Gynaecologists; 2007. (NICE CG57). [Issued December 2007]
    • National Collaborating Centre for Primary Care; National Institute for Health and Care Excellence (commissioner). Atopic eczema in under 12s: diagnosis and management. London: Royal College of Obstetricians and Gynaecologists; 2021. (NICE CG57). [Issued December 2007; updated March 2021]. https://www.nice.org.uk/guidance/cg57

    Antistreptococcal interventions for guttate and chronic plaque psoriasis (Review, 2000)

    • This Cochrane Review has had a direct influence on treatment of psoriasis in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September. http://cks.nice.org.uk/psoriasis
    •  Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of psoriasis and psoriatic arthritis in adults. Edinburgh: SIGN; 2010. (SIGN publication no. 121 http://www.sign.ac.uk/assets/sign121.pdf). [cited 12 Oct 2010]

    Interventions for guttate psoriasis (Review, 2000)

    • This Cochrane Review has had a direct influence on treatment of psoriasis in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Psoriasis. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September

    Laser resurfacing for facial acne scars (Review, 2000)

    • This Cochrane Review has had a direct influence on treatment of acne vulgaris in general practice through CKS: National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Acne vulgaris. [last revised September 2014]. London: National Institute for Health and Care Excellence; 2014 September. http://cks.nice.org.uk/acne-vulgaris

    Drugs for discoid lupus erythematosus (Review, 2000)